Skip to Content

4221 5/500 (Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg)

Generic Name: metformin/saxagliptin

Pill with imprint 4221 5/500 is Brown, Capsule-shape and has been identified as Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg. It is supplied by Bristol-Myers Squibb.

Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4221 5/500

Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 4221 5/500
Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 4221 5/500
Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 4221 5/500
Kombiglyze XR metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg 4221 5/500

Kombiglyze XR

Generic Name
metformin/saxagliptin
Imprint
4221 5/500
Strength
metformin hydrochloride extended-release 500 mg / saxagliptin 5 mg
Color
Brown
Size
20.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
carboxymethylcellulose sodium, hypromellose 2208 (15000 mPa.s), magnesium stearate, microcrystalline cellulose, hypromellose 2910 (15 mPa.s)

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00003-4221
00310-6135 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.